Delivery Order SPE2DB20D7059-SPE2DB25FQLP1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,817.10 firm-fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a $1,055.28 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the PEDVAXHIB vaccine in 0.5 mL vials, with a completion date of September 25, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $2,275.08 for the supply of 4,568,164,194 units of the PEDVAXHIB vaccine. The contract has a firm fixed price and an ultimate completion date of May 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. The company holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,085.49 firm fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials (0.5 mL). The contract has an ultimate completion date of June 24, 2025 and is not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,482.08 firm fixed-price delivery order is for the supply of the PEDVAXHIB vaccine, a 0.5 ML vial. The contract has a completion date of November 21, 2024 and was awarded on November 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $5,928.42 firm fixed-price contract is for the supply of the PEDVAXHIB vaccine in 0.5 ml vials. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical supplies and medications to various federal agencies and healthcare programs. This order is...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDVAXHIB vaccine vials. The $3,385.14 firm fixed-price contract has a completion date of September 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, to provide a comprehensive range of medical commodities supporting...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,211.68 firm fixed-price delivery order is for the provision of PEDVAXHIB 0.5ML 10S, a vaccine product. The award has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PEDVAXHIB vaccine vials. The contract has a potential value of $6,447.60 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under any set-aside designation. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,144.41 firm fixed-price delivery order is for the procurement of PEDVAXHIB vaccine vials (0.5 ml). The contract has a completion date of September 19, 2024 and was awarded on September 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQLP1Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,095.77 award is for the supply of PEDVAXHIB vaccine vials. The contract has an ultimate completion date of July 18, 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order is not a set-aside contract. Amerisourcebergen, as a for-profit organization, is registered in the System for Award Management (SAM.gov) and serves as a critical vendor for federal medical procurement needs, particularly for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 7/17/25 |